Functional properties of human embryonic stem cell-derived cardiomyocytes
Related Experiment Video
Updated: Jun 12, 2026

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
Published on: August 9, 2017
Naama Zeevi-Levin1, Joseph Itskovitz-Eldor, Ofer Binah
1The Sohnis Family Stem Cells Center, and Ruth & Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Insights
Human embryonic stem cell-derived cardiomyocytes (hESC-CM) show promise for repairing heart damage after myocardial infarction. Further understanding their functional properties is crucial for successful cardiac cell therapy.
Area of Science:
- Cardiology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Cardiovascular diseases, particularly myocardial infarction, are leading causes of death globally.
- Congestive heart failure presents significant challenges due to high mortality and limited donor hearts.
- Cell transplantation for myocardial regeneration offers a promising therapeutic avenue.
Purpose of the Study:
- To review the characteristics of human embryonic stem cell-derived cardiomyocytes (hESC-CM).
- To assess the potential of hESC-CM for cardiac repair and regeneration.
- To highlight the importance of understanding hESC-CM functional properties for clinical application.
Main Methods:
- Review of existing literature on hESC-CM.
- Analysis of transcriptional profiles.
- Evaluation of structural and electrophysiological properties.
- Assessment of ion channel expression and excitation-contraction coupling.
- Examination of neurohumoral responsiveness.
Main Results:
- hESC-CM demonstrate cardiac potential and survival after transplantation in infarcted hearts.
- Stable cardiac implants and preserved contractile function have been observed.
- Significant challenges remain in achieving full integration and appropriate physiological response of transplanted hESC-CM.
Conclusions:
- hESC-CM are a viable cell source for cardiac regeneration.
- Comprehensive knowledge of hESC-CM functional properties is essential for effective cardiac repair strategies.
- Further research is needed to overcome challenges in hESC-CM integration and function for therapeutic use.
Abstract:
Cardiovascular diseases are the most frequent cause of death in the industrialized world, with the main contributor being myocardial infarction. Given the high morbidity and mortality rates associated with congestive heart failure, the shortage of donor hearts for transplantation, complications resulting from immunosuppression, and long-term failure of transplanted organs, regeneration of the diseased myocardium by cell transplantation is an attractive therapeutic modality. Because of their remarkable capacity for expansion and unquestioned cardiac potential, pluripotent human embryonic stem cells (hESC) represent an attractive candidate cell source for obtaining cardiomyocytes. Moreover, a number of recent reports have shown that hESC-derived cardiomyocytes (hESC-CM) survive after transplantation into infarcted rodent hearts, form stable cardiac implants, and result in preserved contractile function. Although the latter successes give good reason for optimism, considerable challenges remain in the successful application of hESC-CM to cardiac repair. Because it is desired that the transplanted cells fully integrate within the diseased myocardium, contribute to its contractile performance, and respond appropriately to various physiological stimuli, it is of crucial importance to be familiar with their functional properties. Therefore, this review describes the characteristics of hESC-CM, including their transcriptional profile, structural and electrophysiological properties, ion channel expression, excitation-contraction coupling, and neurohumoral responsiveness.
More Related Videos
13:13High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
Published on: September 23, 2014
10:46Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
Published on: November 3, 2011